Loading...
Please wait, while we are loading the content...
Similar Documents
The use of cardiovascular magnetic resonance as an early non-invasive biomarker for cardiotoxicity in cardio-oncology.
| Content Provider | Europe PMC |
|---|---|
| Author | Burrage, Matthew K. Ferreira, Vanessa M. |
| Copyright Year | 2020 |
| Abstract | Contemporary cancer therapy has resulted in significant survival gains for patients. However, many current and emerging cancer therapies have an associated risk of cardiotoxicity, either acutely or later in life. Regular cardiac screening and surveillance is recommended for patients undergoing treatment for cancer, with emphasis on the early detection of cardiotoxicity before irreversible complications develop. Cardiovascular magnetic resonance imaging is able to accurately assess cardiac structure, function, and perform advanced myocardial tissue characterisation, including perfusion, features which may facilitate the diagnosis and management of cardiotoxicity in cancer survivors. This review outlines the current standards for the diagnosis and screening of cardiotoxicity, with particular focus on current and future applications of cardiovascular magnetic resonance imaging. |
| Related Links | https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7369285&blobtype=pdf |
| ISSN | 22233652 |
| Volume Number | 10 |
| DOI | 10.21037/cdt-20-165 |
| PubMed Central reference number | PMC7369285 |
| Issue Number | 3 |
| PubMed reference number | 32695641 |
| Journal | Cardiovascular Diagnosis and Therapy [Cardiovasc Diagn Ther] |
| e-ISSN | 22233660 |
| Language | English |
| Publisher | AME Publishing Company |
| Publisher Date | 2020-06-01 |
| Access Restriction | Open |
| Rights License | 2020 Cardiovascular Diagnosis and Therapy. All rights reserved. |
| Subject Keyword | Cardiovascular magnetic resonance (CMR) cardio-oncology cardiotoxicity |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cardiology and Cardiovascular Medicine |
